Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This study is examining the safety and effectiveness of two medications, ketamine and
riluzole, in treating patients with treatment resistant major depressive disorder. This study
will also examine the effectiveness of an FDA approved drug called lamotrigine in decreasing
the potential side effects associated with ketamine.
Phase:
Phase 4
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
National Alliance for Research on Schizophrenia and Depression National Center for Research Resources (NCRR)